Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.63M | -61.23M | -45.02M | -45.76M | -45.76M |
| Total Depreciation and Amortization | 1.79M | 1.71M | 1.67M | 1.68M | 1.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.21M | 25.43M | 15.50M | 21.48M | 21.48M |
| Change in Net Operating Assets | -11.21M | -12.40M | -10.81M | -8.13M | -8.13M |
| Cash from Operations | -47.85M | -46.49M | -38.66M | -30.73M | -30.73M |
| Capital Expenditure | -2.67M | -1.40M | -1.47M | -1.23M | -1.23M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 50.00K | 50.00K | 50.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -199.94M | -204.08M | -17.29M | -57.49M | -57.49M |
| Cash from Investing | -202.61M | -205.48M | -18.72M | -58.66M | -58.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 211.20M | 211.17M | 56.00K | 27.00K | 27.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 59.66M | 59.66M | 59.66M | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.81M | -2.93M | -2.93M | -119.00K | -119.00K |
| Cash from Financing | 268.05M | 267.90M | 56.79M | -92.00K | -92.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.59M | 15.93M | -587.00K | -89.48M | -89.48M |